GNLX vs. RXRX
Compare and contrast key facts about Genelux Corporation (GNLX) and Recursion Pharmaceuticals, Inc. (RXRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GNLX or RXRX.
Correlation
The correlation between GNLX and RXRX is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GNLX vs. RXRX - Performance Comparison
Key characteristics
GNLX:
-0.34
RXRX:
-0.25
GNLX:
0.23
RXRX:
0.22
GNLX:
1.03
RXRX:
1.03
GNLX:
-0.40
RXRX:
-0.25
GNLX:
-0.62
RXRX:
-0.43
GNLX:
61.80%
RXRX:
49.53%
GNLX:
113.45%
RXRX:
86.39%
GNLX:
-95.74%
RXRX:
-88.97%
GNLX:
-87.32%
RXRX:
-74.96%
Fundamentals
GNLX:
$180.63M
RXRX:
$4.25B
GNLX:
-$0.94
RXRX:
-$1.54
GNLX:
$8.00K
RXRX:
$54.29M
GNLX:
-$444.00K
RXRX:
$14.55M
GNLX:
-$20.22M
RXRX:
-$262.33M
Returns By Period
In the year-to-date period, GNLX achieves a 104.24% return, which is significantly higher than RXRX's 53.11% return.
GNLX
104.24%
66.78%
119.09%
-34.95%
N/A
N/A
RXRX
53.11%
50.44%
40.82%
-16.33%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GNLX vs. RXRX — Risk-Adjusted Performance Rank
GNLX
RXRX
GNLX vs. RXRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Genelux Corporation (GNLX) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GNLX vs. RXRX - Dividend Comparison
Neither GNLX nor RXRX has paid dividends to shareholders.
Drawdowns
GNLX vs. RXRX - Drawdown Comparison
The maximum GNLX drawdown since its inception was -95.74%, which is greater than RXRX's maximum drawdown of -88.97%. Use the drawdown chart below to compare losses from any high point for GNLX and RXRX. For additional features, visit the drawdowns tool.
Volatility
GNLX vs. RXRX - Volatility Comparison
Genelux Corporation (GNLX) has a higher volatility of 38.76% compared to Recursion Pharmaceuticals, Inc. (RXRX) at 29.87%. This indicates that GNLX's price experiences larger fluctuations and is considered to be riskier than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GNLX vs. RXRX - Financials Comparison
This section allows you to compare key financial metrics between Genelux Corporation and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities